Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.
Evecxia Therapeutics has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Evecxia Therapeutics's investors include Daren Cotter, Viva BioInnovator.
Evecxia Therapeutics is headquartered in Raleigh, United States.
Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.
Evecxia Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evecxia Therapeutics — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/evecxia-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Evecxia Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/evecxia-therapeutics
{{cite web |title=Evecxia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/evecxia-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated